Radioconjugate | ApexOnco - Clinical Trials news and analysis

x

“Top quality, fast and so easy to use”

Director New Product Planning

Morphosys

Click here for more information

Data insights Trial results

30 August 2023

Point looks to make a year-end Splash

The company’s radiopharmaceutical PNT2002 faces a major fourth-quarter catalyst, and US filing could follow.

Subscribe to Radioconjugate